Joe remained silent for almost 18 months after he took over
Joe remained silent for almost 18 months after he took over the CEO position in early 2017.it was such a long time of silence that I had given up hope for a positive outcome in regards to my investment in GNBT a second time
Still Joe was working behind closed doors in - what appeared back then - the best interests of the company and is shareholders, and came out with great news that caused the pps to increase 50+ fold. What makes everyone think that he is now doing exactly that still?
Yes, I have seen those posts about law suits, and for sure I do not think this behavior is appropriate for a CEO, especially that of a publicly traded company, but hey we have seen his behavior on here and his questionable ways to communicate with us, so such emails, that he is now being faced with, do not really shock or surprise me.
Still, I count on him still working in the best interests of the company and that, once it will be possible for him again, to come out with updates on what he and his team were able to accomplish in the time since the last CC.
As a reminder, there is much more to this company and investment than the covid vaccine business, and there is much more value in this company (many times) than the current market cap wants to make us believe. And not the worst of all CEOs, will be able to ruin it all, as long as he is not doing this on purpose and /or just for the purpose to enrich himself. We do not have any reason to be believe that the latter is the case.
5
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Care at Home with Artificial Intelligence Recent advancements in artificial intelligence (AI) are significant, capturing the attention of care at home providers. With insights drawn from a comprehensive survey conducted by Axxess, the Council of State Associations, and the Forum of States, the 2025 Care at Home Industry Trends Report highlights AI as the top...
Continue Reading
LaPour Announces New Tenant at Creekside Centennial Tech Center LaPour, in collaboration with Mar-Gulf Management Inc. and MDI Capital, has achieved an exciting milestone at the Creekside Centennial Tech Center (CCTC). The announcement involves securing its second tenant, The Performance Shift, LLC, which will occupy an impressive space of 9,571 RSF of shallow bay...
Continue Reading
Capri Holdings Class Action Lawsuit Overview Right now, an important class action lawsuit is taking shape that involves Capri Holdings Limited (NYSE: CPRI). Investors who believe they have suffered losses exceeding $50,000 are encouraged to engage and learn about their options. The lawsuit is spearheaded by Faruqi & Faruqi, LLP, a dedicated national securities law firm...
Continue Reading
The Future of the Proteomics Market The global proteomics market is on an upward trajectory, with an estimated value of around USD 33.6 billion in 2024. This market is expected to grow significantly, reaching an impressive USD 60.5 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.4% during this period. Factors Driving Market Growth Several key...
Continue Reading
Markel Insurance Strengthens Its Leadership in Malaysia Markel Insurance, part of Markel Group Inc. (NYSE: MKL), has recently announced a significant leadership change with the appointment of Jasminder Kaur as Principal Officer for Malaysia. This pivotal role underscores Markel's ambition to expand its operations within the burgeoning Southeast Asian market. Strategic...
Continue Reading